Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. They invest in novel science and innovative approaches to bring promising drug candidates to patients and accelerate their progress by actively supporting young drug development companies to achieve clinical proof of concept with their lead programs. Droia has an in-house team of experts and drug development professionals who follow the portfolio companies closely and provide hands-on support. Droia invests in early financing rounds and incubates new companies.

Venture Capital

Droia Ventures

Janwillem Naesens

Alexander Depauw

Carmen Bravo

Nele Vandervoort

Willem-Jan Wollants

Guy Eelen

Javier Perales-Patón

Elke Van Oudenhove

An Steensels

Kris Nys

Athanasios Didangelos

Matthias Van Woensel

Sara Morren

Thomas Martz

Evelien Verdrengh

Lenny Van Steenhuyse

George Golumbeski

Sandra Schoors

Matthias De Witte

Sebastian Bernales

Luc Dochez

The Advisory Team at Droia Ventures offers strategic guidance and expert advice to portfolio companies, leveraging their extensive knowledge in drug development and innovative scientific approaches. Comprising advisors and scientific analysts, they closely monitor and actively support these companies, helping accelerate the development and clinical proof of concept for promising drug candidates.

Advisory Team

Droia Labs Team

Leadership Team

Advisory Team

About

Team members

Other teams at Droia Ventures

Droia Labs Team

Leadership Team